3-hydroxybutyrate

N/A

Report date: 2022/11/13 11:44:49
NME

Base Information

Drug Name3-hydroxybutyrate
Drug Alias Name3-OHBNa-3-OHB
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHydroxycarboxylic acid receptor 2 agonists
TargetsHydroxycarboxylic acid receptor 2
Therapy Area/IndicationsKetosisHeart Failure, Systolic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAarhus University
China Registration ClassN/A

Develop Information

Active CompaniesAarhus University
Inactive CompaniesN/A
Active IndicationsKetosisHeart Failure, Systolic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A